JP2022546806A5 - - Google Patents
Info
- Publication number
- JP2022546806A5 JP2022546806A5 JP2022513248A JP2022513248A JP2022546806A5 JP 2022546806 A5 JP2022546806 A5 JP 2022546806A5 JP 2022513248 A JP2022513248 A JP 2022513248A JP 2022513248 A JP2022513248 A JP 2022513248A JP 2022546806 A5 JP2022546806 A5 JP 2022546806A5
- Authority
- JP
- Japan
- Prior art keywords
- aliphatic
- group
- tumor
- independently
- independently selected
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025115718A JP2025148436A (ja) | 2019-09-04 | 2025-07-09 | 癌免疫療法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2019903262A AU2019903262A0 (en) | 2019-09-04 | Cancer immunotherapy | |
| AU2019903262 | 2019-09-04 | ||
| AU2019904864A AU2019904864A0 (en) | 2019-12-20 | Cancer immunotherapy (2) | |
| AU2019904864 | 2019-12-20 | ||
| PCT/AU2020/050932 WO2021042171A1 (en) | 2019-09-04 | 2020-09-04 | Cancer immunotherapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025115718A Division JP2025148436A (ja) | 2019-09-04 | 2025-07-09 | 癌免疫療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022546806A JP2022546806A (ja) | 2022-11-09 |
| JP2022546806A5 true JP2022546806A5 (https=) | 2023-09-12 |
Family
ID=74851930
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022513248A Pending JP2022546806A (ja) | 2019-09-04 | 2020-09-04 | 癌免疫療法 |
| JP2025115718A Pending JP2025148436A (ja) | 2019-09-04 | 2025-07-09 | 癌免疫療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025115718A Pending JP2025148436A (ja) | 2019-09-04 | 2025-07-09 | 癌免疫療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230043518A1 (https=) |
| EP (1) | EP4025204A4 (https=) |
| JP (2) | JP2022546806A (https=) |
| CN (2) | CN121371186A (https=) |
| AU (1) | AU2020340468A1 (https=) |
| WO (1) | WO2021042171A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2618842B1 (en) | 2010-09-22 | 2019-04-24 | Ena Therapeutics Pty Ltd | Novel immunostimulatory method |
| AU2018391325B2 (en) | 2017-12-21 | 2024-07-11 | Axelia Oncology Pty Ltd | Optimised compounds |
| MX2021015961A (es) | 2019-06-26 | 2022-03-22 | Ena Respiratory Pty Ltd | Moleculas novedosas. |
| US20220347146A1 (en) * | 2019-09-04 | 2022-11-03 | Axelia Oncology Pty Ltd | Cancer treatment |
| WO2023154799A1 (en) | 2022-02-14 | 2023-08-17 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Combination immunotherapy for treating cancer |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100872472B1 (ko) * | 2003-05-15 | 2008-12-05 | 도꾸리쯔교세이호징 가가꾸 기쥬쯔 신꼬 기꼬 | 면역자극제 |
| GB0907989D0 (en) * | 2009-05-08 | 2009-06-24 | Hybrid Systems Ltd | Multivalent adjuvant display |
| EP2618842B1 (en) * | 2010-09-22 | 2019-04-24 | Ena Therapeutics Pty Ltd | Novel immunostimulatory method |
| CN113876945A (zh) * | 2011-10-06 | 2022-01-04 | 免疫疫苗技术有限公司 | 包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用 |
| EP3328418A1 (en) * | 2015-07-29 | 2018-06-06 | Novartis AG | Combination therapies comprising antibody molecules to pd-1 |
| PL3429618T3 (pl) * | 2016-03-16 | 2024-07-01 | Amal Therapeutics Sa | Kombinacja modulatora immunologicznego punktu kontrolnego i kompleks zawierający peptyd penetrujący komórkę, cargo i agonistę peptydu tlr do zastosowania w medycynie |
| CN110461351B (zh) * | 2017-03-31 | 2024-03-26 | 艾娜呼吸私人有限公司 | 用tlr2激动剂治疗呼吸道感染 |
| AU2018391325B2 (en) * | 2017-12-21 | 2024-07-11 | Axelia Oncology Pty Ltd | Optimised compounds |
-
2020
- 2020-09-04 AU AU2020340468A patent/AU2020340468A1/en active Pending
- 2020-09-04 CN CN202511778268.2A patent/CN121371186A/zh active Pending
- 2020-09-04 WO PCT/AU2020/050932 patent/WO2021042171A1/en not_active Ceased
- 2020-09-04 JP JP2022513248A patent/JP2022546806A/ja active Pending
- 2020-09-04 CN CN202080061095.1A patent/CN114364378A/zh active Pending
- 2020-09-04 US US17/640,704 patent/US20230043518A1/en active Pending
- 2020-09-04 EP EP20860787.9A patent/EP4025204A4/en active Pending
-
2025
- 2025-07-09 JP JP2025115718A patent/JP2025148436A/ja active Pending